- Interpretable dimensionality reduction of single cell transcriptome data with deep generative models.
- The RNA-binding protein YBX1 regulates epidermal progenitors at a posttranscriptional level.
- Characteristics and outcome of the COEUR Canadian validation cohort for ovarian cancer biomarkers.
- Identification of cancer-associated missense mutations in hace1 that impair cell growth control and Rac1 ubiquitylation.
April 25, 2013
Press Release from Genome BC Press Release from Genome Canada Dr. Sohrab Shah awarded two grants in the Canadian Institutes of Health Research / Genome Canada 2012 Bioinformatics And Computational Biology Competition: 1. Measuring and modeling tumour evolution from next generation sequencing data: enabling clinical study of clonal diversity in cancer patients 2. Computational interpretation of […]
October 1, 2012
From the CIHR Annual Report 2011-12: “A team of researchers has found a way to produce the key medical isotope technetium-99m using cyclotrons. Tens of millions of medical procedures are conducted around the world each year using technetium-99m for detecting disease in the heart and bones, as well as elsewhere in the body. Two aging […]
December 28, 2011
Dr. David Huntsman and colleagues, including Drs. Aparicio, Sorensen and Shah, have identified mutations in a gene called DICER in rare, seemingly unrelated ovarian, uterine, and testicular cancers. When the group began sequencing the genomes of these and other rare tumours, they expected to find different gene mutations in each form of the disease. However, […]
Posted in Aparicio Lab, Media, News And Events, Papers, Shah Lab, Sorensen Lab | Tagged with Aparicio, BCCF, BCCRC, Cancer, CIHR, Genome BC, GSC, Huntsman, Morin, MSFHR, NEJM, Research, Shah, Sorensen, UBC